RecruitingPHASE1INTERVENTIONAL

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants

This study, called ALXN2230, is a very early-stage trial (Phase 1) focused on checking the safety and how healthy volunteers react to a new medicine. We want to understand if it's well-tolerated and how it acts inside the body. Some participants will receive the new medicine, while others will get a placebo (a dummy treatment). Both men and women between 18 and 65 years old can take part, as long as they are generally healthy and meet specific health requirements. The study will involve a small number of people, divided into different groups to test different doses. Your health will be carefully monitored throughout. This is a vital first step in developing potential new treatments.

At a glance

Status

Recruiting

Phase

PHASE1

Sponsor

Alexion Pharmaceuticals, Inc.

Enrolment target

Start

26 Mar 2026

Estimated completion

23 Dec 2026

Healthy Adult Participants

What is this study about?

This study is about a new medicine called ALXN2230. It's a very early-stage trial, referred to as 'Phase 1'. The main goal at this stage isn't to treat a specific illness, but to understand if the new medicine is safe for people and how their bodies handle it. Researchers will be looking at things like side effects and how the medicine moves through the body, how much of it stays, and how it's eventually removed.

To do this, a small number of healthy adults will be asked to take part. Some will receive ALXN2230, and others will get a placebo. A placebo is a treatment that looks exactly like the real medicine but contains no active drug. This helps researchers compare the effects of the new medicine accurately. This kind of study is crucial because it provides the foundational information needed before the medicine can be tested in people who are actually ill.

The information gathered from this study is really important. It helps scientists decide if ALXN2230 is safe enough to move on to larger studies and potentially become a treatment for certain conditions in the future. By joining, you'd be contributing valuable data to medical research, helping to advance our understanding of new medicines.

Key takeaways

This study is testing the safety of a new medicine (ALXN2230) in healthy adults.
It's a very early-stage trial (Phase 1).
Some participants will receive the medicine, others a dummy treatment (placebo).
You must be generally healthy and aged 18-65 to participate.
Participation involves medical checks, injections, and regular follow-up visits.
Your contribution helps advance medical research.

Who may be eligible?

To join this study, we're looking for adults who are generally healthy, aged between 18 and 65. You'll have a thorough check-up, including blood tests and a physical exam, to make sure you're suitable.

There are specific health requirements too. For example, your immune system should be working well, and your body weight should be within a certain healthy range. You shouldn't be a smoker or use any nicotine products, and you need to have stopped smoking for at least a year before the study begins.

You wouldn't be able to join if you have a history of serious health problems like heart, kidney, liver, or stomach issues, or certain types of infections or allergies to the study medicine. If you are pregnant or breastfeeding, or have had certain cancers recently, you also wouldn't be eligible. These rules help make sure the study is as safe as possible for participants and that the results are clear.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 18 and 65 years old?
Are you generally healthy and don't have any major ongoing health conditions?
Have you stopped smoking and using nicotine products for at least a year?
Are you not pregnant or breastfeeding?
Do you not have a history of serious allergies to medicines?

Answer every question to see your result.

What does participation involve?

If you decide to take part, you'll first have screening appointments to make sure you meet all the health requirements. This will involve medical history questions, a physical exam, blood tests, and checking your heart.

Once you're accepted, you'll be given either the new medicine, ALXN2230, or a placebo, which looks the same but has no active drug. The medicine will be given as an injection under the skin. You'll be part of a small group, and different groups might receive different amounts of the medicine.

During the study, you'll have several visits to the clinic so doctors can regularly check your health, monitor for any side effects, and take samples (like blood) to see how the medicine is working in your body. The exact number of visits and the total length of your participation will be explained in detail if you are interested, but these types of studies usually involve a period of close monitoring after you receive the dose.

Potential risks and benefits

Taking part in any medical study has potential benefits and risks. For healthy volunteers, the direct benefit to your health is usually limited, as the study isn't designed to treat an illness you have. However, you'll receive thorough medical checks and contribute to important medical research, which could help develop future treatments for others. Potential risks might include discomfort or bruising from injections, possible side effects from the study medicine (which will be carefully monitored), or the inconvenience of study visits. All possible risks will be fully explained to you. Remember, your participation is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Research Site
Verified postcode
London, United Kingdom· Recruiting

Common questions

What is a Phase 1 study?

A Phase 1 study is the first step where a new medicine is tested in people. It mainly focuses on checking if it's safe and how the body handles it, rather than treating a disease.

What is a placebo?

A placebo is a substance that looks exactly like the real medicine but contains no active drug. It helps researchers compare the effects of the new medicine accurately.

Will I know if I'm getting the real medicine or the placebo?

Often in these studies, neither you nor the study team will know who is receiving the active drug and who is receiving the placebo. This is to ensure fair and unbiased results.

How will the medicine be given?

The medicine, or the placebo, will be given as an injection just under your skin, similar to some common vaccines.

What happens if I change my mind?

You are free to leave the study at any time, for any reason. Your decision will not affect your routine medical care.

How to find out more

Alexion Pharmaceuticals, Inc. (Sponsor)

clinicaltrials@alexion.com 1-855-752-2356 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.